21272 ⎘
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient; Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite Steroids, e.g. cholesterol, bile acids or glycyrrhetinic acid
Small molecule-mediated restoration of airway surface physiology in human cystic fibrosis lung epithelia
#302Sustained-release pharmaceutical compositions comprising an immunomodulating agent and uses thereof
#303Delivery and formulation of engineered nucleic acids
#304ARTIFICIAL TEARS
#305Phospholipid-Free Small Unilamellar Vesicles (PFSUVS) for Drug Delivery
#306Sustained-release pharmaceutical compositions comprising a therapeutic agent for treating dementia and uses thereof
#307Lipid nanoparticle formulations for delivery of MRNA
#308NANOPARTICLES BASED ON OPTIONALLY ALKOXYLATED POLY(ALKYL CYANOACRYLATES) HAVING A DEFINED DEGREE OF POLYMERIZATION
#309Pharmaceutical compositions suitable for articular delivery and use thereof in treatment of joint pain
#310Self-assembling oxygen carrier compositions
#311Methods for the preparation of a pharmaceutical-vesicle formulation and associated products and uses
#312Treatment and prevention of injury due to radiation exposure
#313SELF-ASSEMBLED GELS FORMED WITH ANTI-RETROVIRAL DRUGS, PRODRUGS THEREOF, AND PHARMACEUTICAL USES THEREOF
#314NANOLIPOSOME COMPOSITIONS AND METHODS OF USING THE SAME
#315Sustained-release compositions comprising a therapeutic agent for treating depression or anxiety and uses thereof
#316Isoquinoline-steroid conjugates and uses thereof
#317COMPOSITIONS FOR THE DELIVERY OF THERAPEUTIC AGENTS AND METHODS OF USE AND MAKING THEREOF
#318METHOD OF LONG-TERM PRESERVATION OF CHEMICAL AND BIOLOGICAL SPECIES USING SUGAR GLASSES
#319Prostacyclin compounds, compositions and methods of use thereof
#320TUMOR THERAPEUTIC AGENT AND KIT CONTAINING GEMCITABINE LIPOSOME COMPOSITION
#321NOVEL TRITERPENE-GLYCOSIDES AS SWEETENERS OR SWEETENER ENHANCER
#322Artificial exosome composition and related methods
#323LIPID PARTICLE CONTAINING A-TYPE CpG OLIGODEOXYNUCLEOTIDE
#324Compositions for the delivery of therapeutic agents and methods of use and making thereof
#325Composition and methods of RNAi prophylactics and therapeutics for treatment of severe acute respiratory infection caused by 2019 novel coronavirus (2019-nCoV)
#326Injectable slurries and methods of manufacturing and using the same
#327Anhydrous compositions of mTOR inhibitors and methods of use
#328Bubble manufacturing container
#329Compositions and methods for treatment of neurological disorders
#330NANOMATERIALS
#331Nebulizer and container
#332BIPHASIX CANNABINOID DELIVERY
#333Docetaxel palmitate liposome and preparation method thereof
#334LIPOSOMAL ANTICANCER COMPOSITIONS
#335THERAPEUTIC NANOPARTICLES COMPRISING A THERAPEUTIC AGENT AND METHODS OF MAKING AND USING THE SAME
#336NOVEL LIPIDS AND COMPOSITIONS FOR THE DELIVERY OF THERAPEUTICS
#337Compositions for transfecting resistant cell types
#338Targeted delivery of therapeutic agents to human adipocytes
#339Pharmaceutical composition for intraarticular delivery
#340Triglyceride otic formulations and uses thereof
#341Liposomes Useful for Drug Delivery
#342Sustained-release anesthetic compositions and methods of preparation thereof
#343Lipids for use in lipid nanoparticle formulations
#344Lipids for use in lipid nanoparticle formulations
#345SUSTAINED RELEASE OF ANTIINFECTIVES
#346Interactional Biosystem
#347Composition for increasing the expression of a growth factor gene, comprising coreshell structured microparticles as active ingredient
#348Lipids and lipid nanoparticle formulations for delivery of nucleic acids
#349Methods of administering intravenous meloxicam in a bolus dose
#350Combined pharmaceutical formulation comprising drug-containing liposome composition and immune checkpoint inhibitor
#351Liposome composition and method for producing same
#352Injectable Suspensions
#353Controlled release mucoadhesive systems
#354COMPOSITION COMPRISING TETRACYCLIC COMPOUND
#355Lipid-derived neutral nanoparticles
#356Liposome composition and pharmaceutical composition
#357Transdermal carrier
#358Nanostructured gels capable of controlled release of encapsulated agents
#359TRANSMUCOSAL DELIVERY DEVICE AND METHOD OF MANUFACTURING SAME
#360COMPOSITIONS AND THERAPIES USING NANODIAMONDS SUSPENDED IN A CARRIER
#361Blank liposome with ginsenoside Rg3 or its analog as membrane materials and preparations and uses thereof
#362CHIKV RNA vaccines
#363ZIKA VIRUS MRNA VACCINES
#364LONG-ACTING INJECTABLE FORMULATIONS AND USE THEREOF
#365Aqueous formulation for insoluble drugs
#366Sustained-release triptan compositions and method of use the same through subdermal route or the like
#367INJECTABLE PHARMACEUTICAL COMPOSITION CONTAINING MELOXICAM, AND PREPARATION METHOD THEREFOR
#368Aqueous Systems For The Preparation Of Lipid Based Pharmaceutical Compounds; Compositions, Methods, And Uses Thereof
#369Lipid-based nanoparticles and methods using same
#370POLYMERIC BILE ACID NANOPARTICLES AS ANTI-INFLAMMATORY AGENTS
#371Synthetically enveloped virus
#372Anhydrous compositions of mTOR inhibitors and methods of use
#373POLYMERIC BILE ACID ESTER NANOPARTICLES TO INDUCE TOLERANCE
#374VITAMIN COMPOSITION
#375COMPOSITIONS AND METHODS FOR DELIVERING MESSENGER RNA
#376Carbohydrate conjugates as delivery agents for oligonucleotides
#377Drug delivery system containing phospholipid and cholesterol
#378SUSTAINED-RELEASE DRUG CARRIER COMPOSITION
#379Composition of docetaxel liposomal injection with high drug loading
#380Pharmaceutical compositions for intraarticular delivery
#381Lipid-based nanoparticles for encapsulation and sustained release of therapeutic agents
#382LIQUID FORMULATION COMPOSITIONS, MEDICAMENT DELIVERY DEVICES, AND METHODS OF PREPARATION AND USE THEREOF
#383LIPID CONSTRUCT FOR DELIVERY OF INSULIN TO A MAMMAL
#384CRAC CHANNEL INHIBITOR COMPOSITIONS
#385Preparation of desiccated liposomes for use in compressible delivery systems
#386Long-acting non-aqueous injectable formulations and use thereof
#387Liquids rich in noble gas and methods of their preparation and use
#388RNA interference mediated inhibition of hepatitis B virus (HBV) gene expression using short interfering nucleic acid (SINA)
#389Tumor therapeutic agent and kit containing gemcitabine liposome composition
#390Sustained-release anesthetic compositions and methods of preparation thereof
#391Polymer-lipids and compositions
#392LIPOSOMAL PACLITAXEL FORMULATION FOR TREATING BLADDER CANCER
#393RNA interference delivery formulation and methods for malignant tumors
#394Ice-based lipid nanoparticle formulation for delivery of mRNA
#395Nanosome formulations of aprepitant and methods and applications thereof
#396Vaccine adjuvant formulation
#397Reduction of elimination of immune responses to non-intravenous, e.g., subcutaneously administered therapeutic proteins
#398PHARMACEUTICAL COMPOSITION FOR CONTROLLED RELEASE OF WEAK ACID DRUGS AND USES THEREOF
#399Cationic lipid
#400Prostacyclin compounds, compositions and methods of use thereof
#401Isoquinoline-steroid conjugates and uses thereof
#402Varicella zoster virus (VZV) vaccine
#403Pharmaceutical Composition Of S-Ketamine Hydrochloride
#404COMPOSITIONS FOR UPREGULATING DEFENSIN EXPRESSION
#405GLUTATHIONE-CHOLESTEROL DERIVATIVES AS BRAIN TARGETING AGENTS
#406Lipids for delivery of active agents
#407Dihydroartemisinin-steroid conjugate and preparation method and application thereof
#408Ice-based lipid nanoparticle formulation for delivery of mRNA
#409RECONSTITUTED HIGH DENSITY LIPOPROTEIN TREATMENT OF MYOCARDIAL INFARCTION
#410Lipid derivative for nucleic acid introduction
#411DEFORMABLE NANO-SCALE VEHICLES (DNVS) FOR TRANS-BLOOD BRAIN BARRIER, TRANS-MUCOSAL, AND TRANSDERMAL DRUG DELIVERY
#412Liposome composition and pharmaceutical composition
#413Self-assembled gels formed with anti-retroviral drugs, prodrugs thereof, and pharmaceutical uses thereof
#414Anhydrous compositions of mTOR inhibitors and methods of use
#415METHODS AND COMPOSITIONS FOR TREATING OSTEOARTHRITIS AND PROMOTING CARTILAGE FORMATION
#416LIPOSOME PREPARATION HAVING HIGH-CONTENT CATIONIC LIPID COMPOUND AND USE THEREOF
#417Injectable suspension comprising 3-beta-hydroxy-5-alpha-pregnan-20-one, and a method for the manufacturing thereof
#418Artificial exosome composition and related methods
#419Pharmaceutical composition for controlled release of treprostinil
#420Liposome composition and method for producing same
#421Compositions and methods for treating alpha-1 antitrypsin deficiency
#422Methods of treating arthritis
#423Polynucleotides encoding JAGGED1 for the treatment of Alagille syndrome
#424Method of treating pain in elderly patients with mild renal impairment
#425Lipids and lipid nanoparticle formulations for delivery of nucleic acids
#426Liposomal anticancer compositions
#427Prostacyclin compounds, compositions and methods of use thereof
#428Blood-brain barrier permeable heteroduplex nucleic acid
#429Patch-type wound dressing comprising methylene blue mixture for treating skin wound
#430Cationic lipid
#431OXYBUTYNIN-CONTAINING TRANSDERMAL ABSORPTION PREPARATION
#432FORMULATIONS FOR DERMAL DELIVERY OF POLYMER CONJUGATES OF INDOLOCARBAZOLE COMPOUNDS WITH REDUCED EXPOSURE
#433SUSTAINED RELEASE OF ANTIINFECTIVES
#434Injectable composition for localized fat reduction without pain, edema, and side effects, and method for preparing same
#435Lipid-derived neutral nanoparticles
#436Composition for transdermal delivery, comprising nanoemulsion and modified layered double hydroxide
#437Carbohydrate conjugates as delivery agents for oligonucleotides
#438LIPID COMPOSITIONS AND THEIR USES FOR INTRATUMORAL POLYNUCLEOTIDE DELIVERY
#439Lipids and compositions for the delivery of therapeutics
#440Bioerodible implant for long-term drug delivery and associated methods of manufacture and use
#441Coenzyme Q10 solubilizing composition and method for preparing same
#442Methods of Anesthetizing Nerve Tissue in the Trigeminal Nerve Pathway and Medical Uses Thereof
#443Methods for treating pancreatic cancer using combination therapies
#444Pharmaceutical composition of S-ketamine hydrochloride
#445Reversibly crosslinked micelle systems
#446Orally administered nanoparticles for gene delivery and pharmaceutical composition containing same
#447Method of long-term preservation of chemical and biological species using sugar glasses
#448O/W type emulsion
#449Targeting Lipids
#450Adjuvant composition, vaccine composition containing the same, and method for producing both of them
#451Artificial Red Blood Cell Having Ability to Inhibit Conversion of Hemoglobin into Methemoglobin
#452LIPOSOMAL PACLITAXEL PALMITATE FORMULATION AND PREPARATION METHOD THEREOF
#453Sustained-release drug carrier composition
#454Delivery and formulation of engineered nucleic acids
#455Infectious disease vaccines
#456Drug delivery means
#457POLYNUCLEOTIDE FORMULATIONS FOR USE IN THE TREATMENT OF RENAL DISEASES
#458Lipid construct for delivery of insulin to a mammal
#459Sirna/nanoparticle formulations for treatment of middle-east respiratory syndrome coronaviral infection
#460NEGATIVE CONTROL CANNABIS FORMULATIONS
#461Stabilized vancomycin formulations
#462METHODS AND RELATED COMPOSITIONS FOR REDUCTION OF FAT AND SKIN TIGHTENING
#463SUSTAINED RELEASE OF ANTIINFECTIVES
#464COMPOSITIONS FOR DRUG DELIVERY
#465Loxapine film oral dosage form
#466Polynucleotide agents targeting programmed cell death 1 ligand 1 (PD-L1) and methods of use thereof
#467Transdermal carrier
#468Precipitation resistant small molecule drug formulations
#469BIPHASIX CANNABINOID DELIVERY
#470COMPOSITIONS AND METHODS FOR mRNA DELIVERY
#471LIPIDS FOR DELIVERY OF THERAPEUTICS
#472CHIKV RNA vaccines
#473THERAPEUTIC NANOPARTICLES COMPRISING A THERAPEUTIC AGENT AND METHODS OF MAKING AND USING THE SAME
#474Long-acting non-aqueous injectable formulations and use thereof
#475CARBOHYDRATE CONJUGATES AS DELIVERY AGENTS FOR OLIGONUCLEOTIDES
#476Nanostructured gels capable of controlled release of encapsulated agents
#477Formulations of levosimendan for intravenous administration as infusion or injection and of infusion concentrate
#478Composition for intraoral delivery of biologically active peptides and proteins
#479LIPOSOME PRODUCTION USING ISOPROPANOL
#480Bioerodible contraceptive implant and methods of use thereof
#481LIPOPLEXES FORMULATED FOR CATALYTIC DELIVERY
#482Formulations for epidermal repair
#483Zika RNA vaccines
#484LIPOSOME INCLUDING TAXANE COMPOUND
#485TRANSDERMAL CARRIER
#486LIQUIDS RICH IN NOBLE GAS AND METHODS OF THEIR PREPARATION AND USE
#487Compositions and methods for treating viral infections
#488Reduction of flake-like aggregation in nanoparticulate active agent compositions
#489Tumor therapeutic agent and kit containing gemcitabine liposome composition
#490INJECTABLE SOLUTION AT PH 7 COMPRISING AT LEAST ONE BASAL INSULIN THE ISOELECTRIC POINT OF WHICH IS COMPRISED IN 5.8 AND 8.5 AND AN ANIONIC COMPOUND BEARING CARBOXYLATE CHARGES AND HYDROPHOBIC RADICALS
#491Treatment for Spirochete borne illness
#492LIPOSOMES USEFUL FOR DRUG DELIVERY
#493Methods and compositions for therapeutic agents
#494PHARMACEUTICAL COMPOSITION COMPRISING 5ALPHA-REDUCTASE INHIBITOR
#495In situ preparation of cyano-bridged metal nanoparticles within a biocompatible reverse micellar system
#496RNA interference mediated inhibition of hepatitis B Virus (HBV) gene expression using short interfering nucleic acid (siNA)
#497Pharmaceutical compositions to reduce complications of ocular steroid
#498Anyhydrous compositions of mTOR inhibitors and methods of use
#499Ophthalmic drug delivery system containing phospholipid and cholesterol
#500Lipid-derived neutral nanoparticles
#501Lipid-derived neutral nanoparticles
#502Liposomes useful for drug delivery
#503Methods of Anesthetizing Nerve Tissue in the Trigeminal Nerve Pathway and Medical Uses Thereof
#504METHODS FOR POTENTIATING AN IMMUNE RESPONSE USING DEPOT-FORMING AND NON-DEPOT-FORMING VACCINES
#505COMPOSITIONS AND METHODS FOR TREATING MYCOBACTERIA INFECTIONS AND LUNG DISEASE
#506Method of treating carcinoma
#507Lipids and compositions for the delivery of therapeutics
#508Therapeutic nanoparticles comprising a therapeutic agent and methods of making and using the same
#509Method for manufacturing bubbles and bubbles
#510SUSTAINED RELEASE OF ANTIINFECTIVES
#511pH sensitive carrier and preparation method thereof, and pH sensitive drug and pH sensitive drug composition each containing the carrier, and method for treating or preventing diseases using the same
#512Dry powder formulation of azole derivative for inhalation
#513Bubble manufacturing container
#514Lipids and compositions for the delivery of therapeutics
#515Thermostable vaccines based on ether lipids and native viral envelope proteins
#516Bioerodible implant for long-term drug delivery and associated methods of manufacture and use
#517Liposomal formulations of polymyxin B and uses thereof
#518NOVEL LIPIDS AND COMPOSITIONS FOR THE DELIVERY OF THERAPEUTICS
#519Polymeric metformin and its use as a therapeutic agent and as a delivery vehicle
#520Cationic lipid
#521Lipids and compositions for the delivery of therapeutics
#522Methods and compositions for treating osteoarthritis and promoting cartilage formation
#523Compositions and methods for silencing hepatitis B virus gene expression
#524Vesicles comprising epidermal growth factor and compositions thereof
#525Methods for Treating Pancreatic Cancer Using Combination Therapies
#526Methods of treating arthritis
#527MEDICAL DERMATOLOGICAL PREPARATION FOR EXTERNAL USE
#528Liposomes useful for drug delivery
#529Cationic lipid
#530Sucrose ester based cationic gene vector and preparation method thereof
#531NOVEL PHARMACOLOGICAL THERAPY FOR NEUROMUSCULAR CONTRACTURES
#532Activated macrophage targetable drug carrier for treatment of atherosclerosis and methods of preparing the same
#533MICELLE FORMULATIONS OF AMPHOTERICIN B
#534INJECTABLE SLURRIES AND METHODS OF MANUFACTURING AND USING THE SAME
#535Delivery and formulation of engineered nucleic acids
#536Pharmaceutical composition comprising 3-beta-hydroxy-5-alpha-pregnan-20-one with improved storage and solubility properties
#537Pharmaceutical or cosmetic compositions comprising a polymer and an absorption promoter for controlled release of active ingredients
#538Pharmaceutical anti-infective composition for inhalation
#539Nanoparticle-based tumor-targeted drug delivery
#540LOXAPINE FILM ORAL DOSAGE FORM
#541Liposome composition and method for producing same
#542PHOSPHOLIPID DEPOT
#543MESENCHYMAL STEM CELL PARTICLES
#544HIGHLY DRUG-LOADED POLY(ALKYL 2-CYANOACRYLATE) NANOCAPSULES
#545COMPOSITION OF LIPID-BASED NANOPARTICLES FOR SMALL MOLECULES AND MACROMOLECULES
#546DRIED FORMULATIONS OF NANOPARTICLE-COATED CAPSULES
#547Lipids and lipid nanoparticle formulations for delivery of nucleic acids
#548Lipid particles and nucleic acid delivery carrier
#549Lipocationic polymers and uses thereof
#550TRANSDERMAL PHARMACEUTICAL COMPOSITIONS WITH REDUCED SKIN IRRITATION
#551Clear Compositions and Methods for the Delivery of Active Ingredients for Skin Care
#552Liposomes useful for drug delivery
#553LIPOSOMAL COMPOSITIONS FOR MUCOSAL DELIVERY
#554Liposomes useful for drug delivery
#555Compositions for antigen-specific induction of tolerance
#556Liposome composition and method for producing same
#557Liposome composition and method for producing same
#558Nanostructured gels capable of controlled release of entrapped agents
#559TARGETING LIPIDS
#560Methods for treating pancreatic cancer using combination therapies
#561RNA interference mediated inhibition of hepatitis B virus (HBV) gene expression using short interfering nucleic acid (siNA)
#562Transdermal drug delivery system having multi-lamellar emulsion structure
#563Sustained-release drug carrier composition
#564Liposomes Useful for Drug Delivery
#565Composition comprising tetracyclic compound
#566Aqueous Systems For The Preparation Of Lipid Based Pharmaceutical Compounds; Compositions, Methods, And Uses Thereof
#567Compositions with high content of sesamin class compounds
#568Adjuvant composition, vaccine composition containing the same, and method for producing both of them
#569Immunosuppressive treatments, formulations and methods
#570Cationic lipid
#571COMPOSITIONS AND METHODS FOR DELIVERING MESSENGER RNA
#572COMPOSITIONS AND METHODS FOR DELIVERING MESSENGER RNA
#573MODIFIED DOCETAXEL LIPOSOME FORMULATIONS AND USES THEREOF
#574Methods and formulations for transdermal administration
#575Reduction of flake-like aggregation in nanoparticulate active agent compositions
#576Reduction of flake-like aggregation in nanoparticulate active agent compositions
#577Reduction of flake-like aggregation in nanoparticulate active agent compositions
#578Lipocationic polymers and uses thereof
#579Aqueous solution formulation and method for manufacturing same
#580Liposome composition for treating acne containing conjugate of lysophosphatidylcholine and chlorin e6
#581Tyrosine-based lipids for delivery of therapeutics
#582METHODS AND COMPOSITIONS FOR ORAL ADMINISTRATION OF PROTEINS
#583Lipids and compositions for the delivery of therapeutics
#584LOW RESISTANCE AEROSOL EXHALATION FILTER
#585On demand vesicle formation from vesicle precursors suitable for long-term storage
#586Method for the treatment of nanohydrogels
#587Liposomes useful for drug delivery
#588Liposomes useful for drug delivery
#589RNA interference mediated inhibition of hepatitis B virus (HBV) gene expression using short interfering nucleic acid (siNA)
#590Aromatase inhibitor-releasing intravaginal device
#591Carbohydrate conjugates as delivery agents for oligonucleotides
#592Nanoparticles, composed of sterol and saponin from for use in pharmaceutical compositions
#593INTRAVENOUS FORMULATIONS OF TRIPTOLIDE COMPOUNDS AS IMMUNOMODULATORS AND ANTICANCER AGENTS
#594LIQUIDS RICH IN NOBLE GAS AND METHODS OF THEIR PREPARATION AND USE
#595Liposomes useful for drug delivery
#596Composition for gene delivery comprising chitosan and liquid crystal formation material
#597COMPOSITIONS AND METHODS FOR mRNA DELIVERY
#598Drug delivery means
#599Ophthalmic Formulations of Squalamine
#600PROSTACYLIN COMPOSITIONS AND METHODS FOR USING THE SAME